Immunotherapy combo shows promise in Hard-to-Treat ovarian cancer
NCT ID NCT03275506
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 34 times
Summary
This study tested whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard chemotherapy before surgery helps women with advanced ovarian cancer. About 91 participants received either chemo alone or chemo plus pembrolizumab. The goal was to see if the combination leads to more complete tumor removal during surgery and better disease control. While not a cure, this approach aims to improve outcomes for a serious cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER STAGE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Jean Minjoz
Besançon, 25030, France
-
CHU Saint-Etienne - Pôle de Cancérologie
Saint-Priest-en-Jarez, 42271, France
-
Centre CARIO-HPCA
Plérin, 22190, France
-
Centre François Baclesse
Caen, 14000, France
-
Centre Georges François Leclerc
Dijon, 21079, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Hospitalier Départemental Les Oudairies
La Roche-sur-Yon, 85925, France
-
Centre Hospitalier Intercommunal de Créteil
Créteil, 94010, France
-
Centre Hospitalier Régional d'Orléans
Orléans, 45067, France
-
Centre Hospitalier Universitaire Dupuytren
Limoges, 87042, France
-
Centre Jean Perrin
Clermont-Ferrand, 63000, France
-
Centre Léon Bérard
Lyon, 69373, France
-
Clinique Pasteur
Toulouse, 31076, France
-
Groupe Hospitalier Diaconesses-Croix Saint Simon
Paris, 75020, France
-
Hôpital Henri Duffaut
Avignon, 84000, France
-
Hôpital Privé Jean Mermoz
Lyon, 69373, France
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
-
ICO Centre René Gauducheau
Saint-Herblain, 44805, France
-
Institut Claudius Regaud
Toulouse, 31059, France
-
Institut Jean Godinot
Reims, 51056, France
-
Institut Mutualiste Montsouris-Jourdan
Paris, 75674, France
-
Institut Paoli Calmettes
Marseille, 13009, France
Conditions
Explore the condition pages connected to this study.